Minerva Neurosciences, Inc.
NERV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001598646
No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Minerva Neurosciences, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 24 | 33 | +9 |
| Shares | 1.98M | 23.1M | +21.1M (+1,065.4%) |
| Value | $4.21M | $107.7M | +$103.5M (+2,459.5%) |
New holders (14)
Institutions that held Minerva Neurosciences, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vivo Capital, LLC | 4,322,747 | $17.4M | 1.12% |
| Janus Henderson Group PLC | 9,000 | $17.1M | 0.01% |
| Logos Global Management LP | 3,311,000 | $13.3M | 0.89% |
| Adage Capital Partners GP, L.L.C. | 2,838,000 | $11.4M | 0.02% |
| Farallon Capital Management, L.L.C. | 2,365,000 | $9.51M | 0.05% |
| Ally Bridge Group (NY) LLC | 1,655,500 | $6.66M | 10.56% |
| Spruce Street Capital LP | 1,655,500 | $6.66M | 2.20% |
| Acuta Capital Partners, LLC | 709,500 | $2.85M | 1.94% |
| Millennium Management LLC | 137,911 | $554.4K | 0.00% |
| Lion Point Capital, LP | 35,000 | $140.7K | 0.73% |
| Two Sigma Investments, LP | 22,294 | $89.6K | 0.00% |
| Deutsche Bank AG | 1,500 | $6.03K | 0.00% |
| Larson Financial Group LLC | 400 | $1.61K | 0.00% |
| Fortitude Family Office, LLC | 303 | $1.22K | 0.00% |
Sold out (5)
Institutions that held Minerva Neurosciences, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| ADAR1 Capital Management, LLC | 12,406 | $26.1K |
| Rangeley Capital, LLC | 10,000 | $21.1K |
| Groupe la Francaise | 337 | $603 |
| Barclays PLC | 1 | $2 |
| Citigroup Inc | 1 | $2 |